Literature DB >> 1388841

Antigen presentation in virus infection.

N Murray1, A McMichael.   

Abstract

Important recent advances have been made in our understanding of antigen processing of cytoplasmic antigens and presentation by class I molecules of the MHC. Peptide transporter-like molecules encoded within the MHC have been characterized and have, by transfection, corrected some of the presentation-mutant cell lines. The nature of peptide-MHC class I interactions has been clarified by further resolution of the HLA A2 and B27 crystals and elution of peptides. The differences between antigenicity and immunogenicity for viral antigens have been highlighted by studies in transgenic animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388841     DOI: 10.1016/s0952-7915(06)80030-0

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  8 in total

1.  Prediction of an HLA B8-restricted influenza epitope by motif.

Authors:  A Suhrbier; C Schmidt; A Fernan
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

2.  Coronavirus and Its effect on the respiratory system: Is there any association between pneumonia and immune cells.

Authors:  Besharat Rahimi; Ahmad Vesal; Maryam Edalatifard
Journal:  J Family Med Prim Care       Date:  2020-09-30

3.  Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes.

Authors:  S Niewiesk; U Brinckmann; B Bankamp; S Sirak; U G Liebert; V ter Meulen
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

4.  Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine.

Authors:  C Brander; W J Pichler; G Corradin
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

5.  Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.

Authors:  T W Tobery; R F Siliciano
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

Review 6.  Association of coronavirus pathogencity with the level of antioxidants and immune system.

Authors:  Alireza Hejrati; Maryam Nurzadeh; Maryam Roham
Journal:  J Family Med Prim Care       Date:  2021-02-27

7.  Emerging cancer vaccines: the promise of genetic vectors.

Authors:  Luigi Aurisicchio; Gennaro Ciliberto
Journal:  Cancers (Basel)       Date:  2011-09-22       Impact factor: 6.639

8.  A pooled genome-wide screening strategy to identify and rank influenza host restriction factors in cell-based vaccine production platforms.

Authors:  David M Sharon; Sean Nesdoly; Hsin J Yang; Jean-François Gélinas; Yu Xia; Sven Ansorge; Amine A Kamen
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.